Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ENOXAPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 296 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bell, GK; Goldhaber, SZ
      Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

      VASCULAR MEDICINE
    2. Glueck, CJ; Freiberg, RA; Fontaine, RN; Sieve-Smith, L; Wang, P
      Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Attanasio, E; Russo, P; Carunchio, G; Caprino, L
      Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer - A cost-effectiveness analysis

      PHARMACOECONOMICS
    4. Otero, R; Uresandi, F; Cayuela, A; Blanquer, J; Cabezudo, MA; De Gregorio, MA; Lobo, JL; Nauffal, D; Oribe, M
      Use of venous thromboembolism prophylaxis for surgical patients: A multicentre analysis of practice in Spain

      EUROPEAN JOURNAL OF SURGERY
    5. Tapson, VF
      Prophylaxis strategies for patients with acute venous thromboembolism

      AMERICAN JOURNAL OF MANAGED CARE
    6. Trivalle, C; Medjahed, S
      Long-term use of low molecular weight heparin for venous thromboembolism prophylaxis in French geriatric settings

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    7. Turpie, AGG
      Setting a standard for venous thromboembolism prophylaxis

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    8. Dhote, R; Pellicer-Coeuret, M; Belouet-Moreau, C; Christoforov, B; Vidal-Trecan, G
      Venous thromboembolism in medical inpatients: Prophylaxis with low-weight heparin in a university hospital and prevalence of thromboembolic events

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    9. Liu, CY; Yim, BT; Wozniak, AJ
      Anticoagulation therapy for radiation-induced myelopathy

      ANNALS OF PHARMACOTHERAPY
    10. Porras, MC; Martin, MD; Ruiz, MG
      Dalteparin-induced retroperitoneal bleeding

      ANNALS OF PHARMACOTHERAPY
    11. Robitaille, D; Carrier, M; Cartier, R; Perrault, LP; Denault, A; Belisle, S; White, M; Racine, N; Pelletier, G
      Successful management strategy for mechanical assistance and heart transplantation in patients suffering from heparin-induced thrombocytopenia type II

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    12. Thomas, DP
      Thromboprophylaxis after replacement arthroplasty - Anticoagulants are more effective than aspirin

      BRITISH MEDICAL JOURNAL
    13. Elhasid, R; Lanir, N; Sharon, R; Ben Arush, MW; Levin, C; Postovsky, S; Ben Barak, A; Brenner, B
      Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia

      BLOOD COAGULATION & FIBRINOLYSIS
    14. Bendz, B; Sevre, K; Andersen, TO; Sandset, PM
      Low molecular weight heparin prevents activation of coagulation in a hypobaric environment

      BLOOD COAGULATION & FIBRINOLYSIS
    15. Bremme, K; van Rooijen, M; Yu, A; Blomback, M
      Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy

      BLOOD COAGULATION & FIBRINOLYSIS
    16. Pacheco, H; Kerdel, F
      Successful treatment of lichen planus with low-molecular-weight heparin: acase series of seven patients

      JOURNAL OF DERMATOLOGICAL TREATMENT
    17. Malhotra, S; Bhargava, VK; Grover, A; Pandhi, P; Sharma, YP
      A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial)

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    18. Barrett, JS; Gibiansky, E; Hull, RD; Planes, A; Pentikis, H; Hainer, JW; Hua, TA; Gastonguay, M
      Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    19. Schimmelpfennig, L
      Acetylsalicylic acid in venous diseases

      PHLEBOLOGIE
    20. Ziegler, V; Schlesinger, S; Griewing, B; Samland, O
      Bleeding complications in combined treatment with clopidrogel and low-doseheparin in stroke patients

      PERFUSION
    21. Choo, JK; Kereiakes, DJ
      Low molecular weight heparin therapy for percutaneous coronary intervention: A practice in evolution

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    22. Cohen, M
      The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    23. Mesko, JW; Brand, RA; Iorio, R; Gradisar, I; Heekin, R; Leighton, R; Thornberry, R
      Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients - A survey of the AAHKS membership

      JOURNAL OF ARTHROPLASTY
    24. Belmin, J; Medjahed, S; Trivalle, C; Lutzer, P
      Heparin use and risk patterns in geriatric patients: a one-day audit in France

      PRESSE MEDICALE
    25. Sundrani, R; Klein, LW
      Antithrombotic and thrombolytic therapy in acute cardiac care

      CRITICAL CARE CLINICS
    26. Burg, MD; Dallara, JJ
      Rupture of a previously normal spleen in association with enoxaparin: An unusual cause of shock

      JOURNAL OF EMERGENCY MEDICINE
    27. Baykal, C; Al, A; Demirtas, E; Ayhan, A
      Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: A randomised prospective double-blind clinical study

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    28. Vila, V; Martinez-Sales, V; Reganon, E; Peris, E; Perez, F; Ruano, M; Aznar, J
      Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

      HAEMATOLOGICA
    29. Finsen, V
      Duration of thrombosis prophylaxis in orthopaedic surgery

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    30. Huber, K; Niessner, A; Niessner, H
      Low molecular weight heparins in acute coronary syndrome

      HERZ
    31. Cohen, AT; Bailey, CS; Alikhan, R; Cooper, DJ
      Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty - a meta-analysis

      THROMBOSIS AND HAEMOSTASIS
    32. Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Esslinger, HU; Breddin, HK; Harder, S
      Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    33. Prentice, CRM
      Thromboprophylaxis - which treatment for which patients? Author's reply

      JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
    34. Cohen, M
      The role of low-molecular-weight heparin in the management of acute coronary syndromes

      CURRENT OPINION IN CARDIOLOGY
    35. Pollack, CV; Gibler, WB
      Advances create opportunities: Implementing the major tenets of the new unstable angina guidelines in the emergency department

      ANNALS OF EMERGENCY MEDICINE
    36. Lancaster, GI; Lancaster, CJ; Radley, D; Cohen, M
      Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    37. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    38. Figarella, I; Barbaud, A; Lecompte, T; De Maistre, E; Reichert-Penetrat, S; Schmutz, JL
      Cutaneous delayed hypersensitivity reactions to heparins and heparinoids.

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    39. Truong, KM; Amankwa, K; Kucukarslan, S
      Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: A review

      CLINICAL THERAPEUTICS
    40. Eikelboom, JW; Quinlan, DJ; Douketis, JD
      Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials

      LANCET
    41. Hui, CK; Yuen, HF; Ng, IOL; Tsang, KWT; Fong, GCY; Lai, CL
      Low molecular weight heparin-induced liver toxicity

      JOURNAL OF CLINICAL PHARMACOLOGY
    42. Barrett, JS; Hainer, JW; Kornhauser, DM; Gaskill, JL; Hua, TA; Sprogel, P; Johansen, K; van Lier, JJ; Knebel, W; Pieniaszek, HJ
      Anticoagulant pharmacodynamics of tinzaparin following 175 IU/kg subcutaneous administration to healthy volunteers

      THROMBOSIS RESEARCH
    43. Hull, RD; Pineo, GF; MacIsaac, S
      Low-molecular-weight heparin prophylaxis: Preoperative versus postoperative initiation in patients undergoing elective hip surgery

      THROMBOSIS RESEARCH
    44. Heit, JA
      Low-molecular-weight heparin: The optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement

      THROMBOSIS RESEARCH
    45. Davidson, BL; Cohen, AT
      A targeted approach to thrombosis: New data, new perspectives - Introduction

      SEMINARS IN HEMATOLOGY
    46. Cohen, AT; Zaw, HM; Alikhan, R
      Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial

      SEMINARS IN HEMATOLOGY
    47. Fox, KAA
      Antithrombotic therapy in acute coronary syndromes: Key notes from ESSENCEand TIMI 11B

      SEMINARS IN HEMATOLOGY
    48. Ip, BKH; Thomson, AR; Moriarty, HT
      A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin

      PATHOLOGY
    49. de Lemos, JA; Morrow, DA; Bentley, JH; Omland, T; Sabatine, MS; McCabe, CH; Hall, C; Cannon, CP; Braunwald, E
      The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

      NEW ENGLAND JOURNAL OF MEDICINE
    50. Rubio-Terres, C; Pajuelo, F; Margalet, I
      Low-molecular-weight heparins in unstable angina and non-Q-wave myocardialinfarction

      MEDICINA CLINICA
    51. Sarto, A; Rocha, M; Geller, M; Capmany, C; Martinez, M; Quintans, C; Donaldson, M; Pasqualini, RS
      Treatment with enoxaparin adapted to the fertility program in women with early recurrent pregnancy loss and thrombophilia.

      MEDICINA-BUENOS AIRES
    52. Merli, GJ
      Duration of deep vein thrombosis and pulmonary embolism prophylaxis after joint arthroplasty

      MEDICAL CLINICS OF NORTH AMERICA
    53. Spandorfer, J
      The management of anticoagulation before and after procedures

      MEDICAL CLINICS OF NORTH AMERICA
    54. Kuzu, N; Ucar, H
      The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin

      INTERNATIONAL JOURNAL OF NURSING STUDIES
    55. Martin, CMJ; Quintana, JAD; Delgado, JAA; Fernandez, JMC; Romero, AS
      Thromboembolic prophylaxis in acute myocardial infarction

      REVISTA CLINICA ESPANOLA
    56. Colwell, CW
      Low molecular weight heparin prophylaxis in total knee arthroplasty - The answer

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    57. Antman, EM
      The search for replacements for unfractionated heparin

      CIRCULATION
    58. Kiesz, RS; Buszman, P; Martin, JL; Deutsch, E; Rozek, MM; Gaszewska, E; Rewicki, M; Seweryniak, P; Kosmider, M; Tendera, M
      Local delivery of enoxaparin to decrease restenosis after stenting: Results of initial multicenter trial - Polish-American local lovenox NIR assessment study (The POLONIA study)

      CIRCULATION
    59. Leonard, SA; Lydon, A; Walsh, M; Fleming, C; Boylan, J; Shorten, GD
      Does prior administration of enoxaparin influence the effects of levobupivacaine on blood clotting? Assessment using the Thrombelastograph((R))

      BRITISH JOURNAL OF ANAESTHESIA
    60. Turpie, AGG; Antman, EM
      Low-molecular-weight heparins in the treatment of acute coronary syndromes

      ARCHIVES OF INTERNAL MEDICINE
    61. Choussat, R; Attali, P
      Heparin in unstable angina and non Q-wave infarction.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    62. Nurmohamed, MT; Dijkmans, BAC; Dijkmans, BAC
      Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter ofdebate

      ANNALS OF THE RHEUMATIC DISEASES
    63. Holper, EM; Antman, EM; McCabe, CH; Premmereur, J; Gurfinkel, E; Bernink, PJLM; Turpie, AG; de Luna, AB; Lablanche, JM; Fox, KM; Salein, D; Radley, DR; Braunwald, E
      A simple, readily available method for risk stratification of patients with uns unstable angina and non-ST elevation myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    64. Henry, TD; Satran, D; Knox, LL; Iacarella, CL; Laxson, DD; Antman, EM
      Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?

      AMERICAN HEART JOURNAL
    65. Blazing, MA; de Lemos, JA; Dyke, CK; Califf, RM; Bilheimer, D; Braunwald, E
      The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

      AMERICAN HEART JOURNAL
    66. Schreiber, R
      Regarding clinical practice guidelines on the use of warfarin

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    67. Benoni, G; Fredin, H; Knebel, R; Nilsson, P
      Blood conservation with tranexamic acid in total hip arthroplasty - A randomized, double-blind study in 40 primary operations

      ACTA ORTHOPAEDICA SCANDINAVICA
    68. Persson, BM
      Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement - The never-ending story?

      ACTA ORTHOPAEDICA SCANDINAVICA
    69. Intes, O; Renault, JH; Sinquin, C; Zeches-Hanrot, M; Nuzillard, JM
      Fractionation of low-molecular-mass heparin by centrifugal partition chromatography in the ion-exchange displacement mode

      JOURNAL OF CHROMATOGRAPHY A
    70. Antman, EM
      Enoxaparin: a new standard of care

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    71. Grines, CL; Kereiakes, D
      Antithrombotic therapy in the catheterization laboratory: interim analysisof the NICE trials

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    72. Bernink, PJLM
      Restoring patency in acute myocardial infarction: the role of low-molecular-weight heparins

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    73. Hampton, KK
      Thromboprophylaxis in medical patients

      HOSPITAL MEDICINE
    74. Ageno, W; Turpie, AGG
      Therapy of unstable angina with the low molecular weight heparins

      VASCULAR MEDICINE
    75. Nenci, GG; Minciotti, A
      Low molecular weight heparins for arterial thrombosis

      VASCULAR MEDICINE
    76. Wallentin, L
      Low molecular weight heparin in unstable coronary artery disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    77. Seo, P; Locke, CFS
      Current and potential uses of low molecular weight heparin: A review and an economic analysis

      AMERICAN JOURNAL OF MANAGED CARE
    78. Rutschmann, OT; Matchar, DB
      Economics of low-molecular weight heparins

      AMERICAN JOURNAL OF MANAGED CARE
    79. Reddy, P; Pillay, S
      Tinzaparin - A once-daily low-molecular-weight heparin for the treatment of deep vein thrombosis

      FORMULARY
    80. Reinhard, F; Ravnan, MC; Matalka, MS
      Low-molecular-weight heparins: Review of their role for unstable angina/non-Q-wave MI

      FORMULARY
    81. Bollinger, KA; Vermeulen, LC; Davis, SN; Geurkink, EA
      Comparative effectiveness of low-molecular-weight heparins after therapeutic interchange

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    82. Punzalan, RC; Hillery, CA; Montgomery, RR; Scott, JP; Gill, JC
      Low-molecular-weight heparin in thrombotic disease in children and adolescents

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    83. Noda, K; Wada, H; Yamada, N; Noda, N; Gabazza, EC; Kumeda, K; Okugawa, T; Yanoh, K; Ito, M; Nakano, T; Shiku, H; Nobori, T; Kato, H; Toyoda, N
      Changes of hemostatic molecular markers after gynecological surgery

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    84. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    85. Fraisse, F; Holzapfel, L; Coulaud, JM; Simmoneau, G; Bedock, B; Feissel, M; Herbecq, P; Pordes, R; Poussel, JF; Roux, L
      Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    86. Dunaway, KK; Gal, P; Ransom, JL
      Use of enoxaparin in a preterm infant

      ANNALS OF PHARMACOTHERAPY
    87. Zidar, JP
      Combining treatment strategies in the 21st century: Low-molecular-weight heparins in acute coronary syndromes

      JOURNAL OF INVASIVE CARDIOLOGY
    88. White, HD
      Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: Complementary or competing therapies?

      JOURNAL OF INVASIVE CARDIOLOGY
    89. Prifti, E; Bonacchi, M; Leacche, M; Miraldi, F
      Undergoing cardiopulmonary bypass using enoxaparin only during a cardiac transplantation procedure

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    90. Bendz, B; Andersen, TO; Sandset, PM
      Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

      BLOOD COAGULATION & FIBRINOLYSIS
    91. Mildner, A; Hilbe, G
      Bleeding complications in varicose vein surgery: relationship with perioperative thromboprophylaxis with LMWH as well as operating in a bloodless field using a tourniquet

      PHLEBOLOGIE
    92. Spencer, FA; Ball, SP; Zhang, QL; Liu, LB; Benoit, S; Becker, RC
      Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    93. Cohen, M; Maritz, F; Gensini, GF; Danchin, N; Timerman, A; Huber, K; Gurfinkel, EP; White, H; Fox, KAA; Vittori, L; Le-Louer, V; Bigonzi, F
      The TETAMI trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in thetreatment of acute myocardial infarction for patients not thrombolyzed: Methods and design

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    94. Wahl, F; Grosjean-Piot, O; Bareyre, F; Uzan, A; Stutzmann, JM
      Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats

      JOURNAL OF NEUROTRAUMA
    95. Burke, DE
      Prevention of deep venous thrombosis - Overview of available therapy options for rehabilitation patients

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    96. Muntz, JE
      Prevention of thromboembolic complications in the rehabilitation center - Diagnostic and risk factor stratification tools

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    97. Stern, SH; Wixson, RL; O'Connor, D
      Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty

      JOURNAL OF ARTHROPLASTY
    98. Ambrosi, P; Calise, G; Villani, P; Luccioni, R; Bouvenot, G
      Prescription of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients

      PRESSE MEDICALE
    99. Fagot, JP; Flahault, A; Kanfer, A; Benoit, G; Bellanger, A; Conort, O; Durand-Zaleski, I; Liote, H; Mangin, L; Oliary, J; Verdy, E; Becker, A
      Prevention of venous thromboembolism in patients hospitalized for more than 24 hours in a medical ward: proposed indications for low molecular weightheparins

      PRESSE MEDICALE
    100. Kaul, S; Shah, PK
      Low molecular weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin?

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 04:11:03